Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized trial of Breezula (CB-03-01) solution in male androgenetic alopecia
2016-003733-23Phase 2Completed
- Sponsor
- Cassiopea S.p.A.
- Start
- Jan 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of clascoterone in androgenetic alopecia (AGA) (5 arms), sponsored by Cassiopea S.p.A. Started Jan 2017; status: completed.
02
Drugs
clascoterone
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on 2016-003733-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-003733-23.